NEW HAVEN, Conn., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will give a corporate presentation at the upcoming Canaccord Adams 29th Annual Global Growth Conference on Tuesday, August 11, 2009 at 1:00 p.m. EDT at the InterContinental Boston Hotel.
